Trial Profile
Pharmacokinetics and clinical outcomes of bortezomib in patients with newly diagnosed myeloma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2011
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 02 Sep 2011 New trial record